FDA Inspection
Piramal Pharma LimitedPiramal Pharma Limited – FDA Inspection, Feb 21, 2017
Record Details
This FDA Inspection record concerns Piramal Pharma Limited, with an inspection on February 21, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Daniel J. Roberts (FDA Associated Person)
- Paula Katz (Issuing Officer)
View Company Profile
ID · 4d5108d6-21cc-4fe9-b32e-d5c82096ac34
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1005197
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Piramal Pharma Limited
8| Date | Classification | Office | Project area |
|---|---|---|---|
| May 19, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 30, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 18, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 30, 2015 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| April 3, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Piramal Pharma Limited
- FDA Inspection 1208559 - 2023-05-19
- FDA Inspection 1103288 - 2019-08-30
- FDA Inspection 1081925 - 2019-01-18
- FDA Inspection 951067 - 2015-10-30
- FDA Inspection 924411 - 2015-04-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.